Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies

Mycoses. 2010 Jan;53(1):89-92. doi: 10.1111/j.1439-0507.2008.01672.x. Epub 2009 Feb 3.

Abstract

We report two cases of invasive zygomycoses occurring in severely immunocompromised patients with haematological malignancies that were successfully treated with liposomal amphotericin B and surgical debridement, followed by oral administration of posaconazole. These cases demonstrated that an early instituted, aggressive and combined therapeutic approach results in a recovery from invasive fungal infection, without any relapse of infection, thanks to secondary prophylaxis using posaconazole.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use
  • Hematologic Neoplasms / complications*
  • Humans
  • Immunocompromised Host
  • Male
  • Middle Aged
  • Treatment Outcome
  • Triazoles / therapeutic use
  • Zygomycosis / drug therapy*
  • Zygomycosis / surgery*

Substances

  • Antifungal Agents
  • Triazoles
  • liposomal amphotericin B
  • posaconazole
  • Amphotericin B